Naloxone Accord (Naloxone Hydrochloride)

Naloxone Accord is an opioid antagonist indicated for conditions involving opioid‑mediated respiratory compromise.

• Opioid overdose: rapid reversal of life‑threatening respiratory depression and loss of consciousness.
• Opioid‑induced respiratory depression: restores normal breathing in patients receiving opioid analgesia.
• Opioid toxicity in emergency care: provides immediate antagonism to prevent fatal outcomes.

• Naloxone Hydrochloride acts as a competitive antagonist at mu‑opioid receptors, displacing opioid agonists and blocking their activation. By occupying these receptors without activating them, it rapidly reverses opioid‑induced central nervous system depression, restoring respiratory drive and consciousness. The antagonistic effect is dose‑dependent and short‑acting, requiring careful monitoring after administration.

Naloxone Accord may cause a range of adverse reactions following administration.

Common Side Effects

• Nausea: mild to moderate feeling of sickness.
• Vomiting: occasional emesis after injection.
• Sweating: increased perspiration.
• Headache: transient cranial pain.
• Agitation: restlessness or anxiety.
• Elevated blood pressure: mild rise in systolic pressure.

Serious or Rare Side Effects

• Severe hypertension: marked increase in blood pressure requiring intervention.
• Cardiac arrhythmia: irregular heart rhythm.
• Pulmonary edema: fluid accumulation in lungs.
• Seizures: convulsive episodes.
• Anaphylaxis: acute allergic reaction with airway compromise.
• Acute opioid withdrawal: severe withdrawal symptoms in dependent individuals.

Naloxone Accord should be used with specific safety considerations.

• Assess opioid dependence: anticipate possible acute withdrawal symptoms.
• Monitor respiratory status: observe for recurrent depression after initial reversal.
• Avoid in patients with known hypersensitivity to naloxone or formulation components.
• Use with caution in cardiovascular disease: watch for hypertension or arrhythmia.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Naloxone may interact with other medications, requiring attention to the level of risk.

Major Interactions (Avoid)

• Combined use with potent opioids: can precipitate severe withdrawal.
• Use with mixed agonist‑antagonist opioids (e.g., buprenorphine): may reduce efficacy of naloxone.

Moderate Interactions (Monitor Closely)

• Concurrent sedatives (benzodiazepines, barbiturates): additive central nervous system depression.
• Monoamine oxidase inhibitors (MAOIs): may enhance opioid effects and complicate reversal.
• Tricyclic antidepressants: increased risk of cardiac effects when rapid opioid antagonism occurs.
• Antihypertensive agents: possible abrupt blood pressure changes after naloxone administration.